The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome

Current Opinion in Pharmacology
Alyson P Black, Anand S Mehta

Abstract

Hepatocellular carcinoma (HCC) is the 5th most common cancer, but the 3rd leading cause of cancer death globally with approximately 700,000 fatalities annually. The severity of this cancer arises from its difficulty to detect and treat. The major etiologies of HCC are liver fibrosis or cirrhosis from chronic viral infections, as well as metabolic conditions. Since most cases arise from prior pathologies, biomarker surveillance in high-risk individuals is an essential approach for early detection and improved patient outcome. While many molecular biomarkers have been associated with HCC, there are few that have made clinical impact for this disease. Here we review some major approaches used for HCC biomarker discovery-proteomics and glycomics-and describe new methodologies being tested for biomarker development.

Citations

Aug 23, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Peter R GalleAndrew X Zhu
Sep 27, 2018·World Journal of Gastroenterology : WJG·Matthias Ocker
Jul 25, 2019·World Journal of Gastroenterology : WJG·Daniel NeureiterMatthias Ocker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Related Papers

Advances in Cancer Research
Anand S MehtaTimothy Block
The Journal of General Virology
Martin R HiggsHervé Lerat
Current Opinion in Infectious Diseases
Carol Beadling, Mark K Slifka
© 2022 Meta ULC. All rights reserved